Skip to Main Content

Paper Details

A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.
Cancer Discov
19
2023
AML, BCL2, CD14, CD34, CD36, CD4, LSC, LSC subclass, Monocytic Leukemia, Monocytic Leukemia Stem Cell, Venetoclax, acute myeloid leukemia, cladribine, human, human acute myeloid LSC, leukemia, leukemia stem cell, m-, m-LSC, m-LSCs, monocytic LSC, monocytic disease, p-LSC, p-LSC subtypes, patient, patients, primitive LSC, purine, tumor, venetoclax
Author NameAffiliation
Shanshan Peithe First Affiliated Hospital, Zhejiang University
Shanshan PeiZhejiang University
Shanshan PeiInstitute of Hematology, Zhejiang University
Shanshan Pei
Brett M StevensUniversity of Colorado School of Medicine
Maura GasparettoUniversity of Colorado School of Medicine
Tonya BrunettiUniversity of Colorado Cancer Center, University of Colorado Anschutz Medical Campus
Tonya BrunettiUniversity of Colorado Anschutz Medical Campus
Maria AmayaUniversity of Colorado School of Medicine
Maria AmayaRocky Mountain Regional VA Medical Center
Mohammad MinhajuddinUniversity of Colorado School of Medicine
Amanda WintersCenter for Cancer and Blood Disorders, University of Colorado
Sweta B PatelUniversity of Colorado School of Medicine
Sweta B PatelUniversity of Colorado School of Medicine
Clayton A SmithUniversity of Colorado School of Medicine
Daniel A PollyeaUniversity of Colorado School of Medicine
Veronica Clavijo JordanUniversity of Colorado School of Medicine
Veronica Clavijo JordanUniversity of Colorado School of Medicine
  • 1 - 18

Datasets

Release 1.2